Sucralfate

Product NDC: 0121-0974
11-digit product format: 001210974
Labeler code: 0121
Product ID: 0121-0974_2271d920-944f-42ac-9de4-2c09447a55b3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Sucralfate
Dosage form: SUSPENSION
Route: ORAL
Labeler: PAI Holdings, LLC dba PAI Pharma
Application: ANDA211884
Marketing category: ANDA
Marketing start: 2022-03-15
Substance: SUCRALFATE
Active strength: 1 g/10mL
Pharmacologic classes: Aluminum Complex [EPC], Organometallic Compounds [CS]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A211884-001	SUCRALFATE	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB	RS	2022-03-15

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A211884-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`5d02ea3f76ae…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB		2022-03-15	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A211884-001	SUCRALFATE	1GM/10ML	SUSPENSION / ORAL	AB	RS	2022-03-15	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A211884-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A211884-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A211884-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A211884-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A211884-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A211884-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A211884-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A211884-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A211884-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A211884-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A211884-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A211884-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A211884-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A211884-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211884-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211884-001	AB	1	`5d02ea3f76ae…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A211884-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A211884-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A211884-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A211884-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A211884-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A211884-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A211884-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A211884-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A211884-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A211884-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A211884-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A211884-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A211884-001	AB	1	`cb3db0bc1861…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A211884-001	AB	1	`a50c72e98297…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A211884-001	CGT	2022-09-11	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A211884-001	CGT	2022-09-11	`5d02ea3f76ae…`
2023-01-26 05:58 UTC	2023-01	A211884-001	CGT	2022-09-11	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A211884-001	CGT	2022-09-11	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A211884-001	CGT	2022-09-11	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A211884-001	CGT	2022-09-11	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A211884-001	CGT	2022-09-11	`cb3db0bc1861…`

Additional Listing Data#

Finished product: Yes
Brand name base: Sucralfate
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
SUCRALFATE	1 g/10mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
XX73205DH5	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
313123	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
113a068a-2ce9-421c-8b89-87ce30e19225	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
01e96ee1-fe82-0132-025c-ec1559bf8b6e	Product name	5	20260127
f9fa5fa8-e047-2182-3e2c-c4a9ec6531cd	Product name	3	20240508
c6f86816-7da6-43ea-8c25-ac9758311cc5	Product name	1	20220118
252e11b6-1a9a-4283-a242-df2c129c496d	Product name	3	20170717
6084a4f4-5437-c9a5-caec-5361ee075a59	Product name	1	20140508
90c5639a-61b0-88d6-ddcf-21888e94869a	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
0121-0974-00	Sucralfate	10 in 1 TRAY	SUSPENSION	10	6
0121-0974-10	Sucralfate	10 mL in 1 CUP, UNIT-DOSE	SUSPENSION	10	6
0121-0974-40	Sucralfate	4 in 1 CASE	SUSPENSION	4	6
0121-0974-40	Sucralfate	10 in 1 TRAY	SUSPENSION	10	6
0121-0974-50	Sucralfate	5 in 1 TRAY	SUSPENSION	5	6
0121-0974-50	Sucralfate	10 in 1 PACKAGE	SUSPENSION	10	6
0121-0974-94	Sucralfate	3 in 1 CASE	SUSPENSION	3	6
0121-0974-94	Sucralfate	10 in 1 TRAY	SUSPENSION	10	6

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0121-0974-00	ML - Milliliter	0121-0974	f00e0171-7f21-4759-95fd-9db0732d27f0	1	2022-11-07
0121-0974-10	ML - Milliliter	0121-0974	b316a3df-3cac-4e30-b029-f6be868e2958	1	2022-11-07
0121-0974-40	ML - Milliliter	0121-0974	e8459b92-2e2b-4d29-959e-5b056e073b9a	1	2022-11-07
0121-0974-50	ML - Milliliter	0121-0974	e34e67d0-9212-47e9-bf47-2a33d62d9292	1	2022-11-07
0121-0974-94	ML - Milliliter	0121-0974	366d8610-7cdd-448d-9923-be8e4882017e	1	2022-11-07

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
0121-0974	SUCRALFATE SUSPENSION [PAI HOLDINGS, LLC DBA PAI PHARMA]	5	Current NDC, Legacy NDC, 8 package rows	20240316_113a068a-2ce9-421c-8b89-87ce30e19225.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Sucralfate	SUCRALFATE	Cardinal Health 107, LLC	92c8672a-c6b8-4ec8-a815-c30bdd960ac7	2026-03-30	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211884 application number: ANDA211884
Sucralfate	SUCRALFATE	PAI Holdings, LLC dba PAI Pharma	113a068a-2ce9-421c-8b89-87ce30e19225	2026-03-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211884 application number: ANDA211884 ndc (product): 0121-0974
Sucralfate	SUCRALFATE ORAL SUSPENSION	Major Pharmaceuticals	98a8fedd-fa06-416a-8a85-b899631978f9	2026-02-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211884 application number: ANDA211884
Sucralfate	SUCRALFATE	ATLANTIC BIOLOGICALS CORP.	e5073597-ac51-4e7c-a9dc-7695773a01f1	2025-05-27	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211884 application number: ANDA211884
Sucralfate	SUCRALFATE	VistaPharm, LLC	cbfbe146-5d42-4a55-9050-df2b5581487a	2023-12-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211884 application number: ANDA211884
Sucralfate	SUCRALFATE	American Health Packaging	e4761fb2-6a1a-44de-9d27-f6addabc24c8	2023-08-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 211884 application number: ANDA211884

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
XX73205DH5	SUCRALFATE	54182-58-0	SUCRALFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
313123	sucralfate 1 GM in 10 mL Oral Suspension	PSN	113a068a-2ce9-421c-8b89-87ce30e19225	6
313123	sucralfate 100 MG/ML Oral Suspension	SCD	113a068a-2ce9-421c-8b89-87ce30e19225	6
313123	sucralfate 1 GM per 10 ML Oral Suspension	SY	113a068a-2ce9-421c-8b89-87ce30e19225	6
313123	sucralfate 1 GM in 10 mL Oral Suspension	PSN	92c8672a-c6b8-4ec8-a815-c30bdd960ac7	5
313123	sucralfate 1 GM in 10 mL Oral Suspension	PSN	c76c7bcb-d481-43ff-809b-da8e0e88f096	5
313123	sucralfate 100 MG/ML Oral Suspension	SCD	92c8672a-c6b8-4ec8-a815-c30bdd960ac7	5
313123	sucralfate 100 MG/ML Oral Suspension	SCD	c76c7bcb-d481-43ff-809b-da8e0e88f096	5
313123	sucralfate 1 GM per 10 ML Oral Suspension	SY	92c8672a-c6b8-4ec8-a815-c30bdd960ac7	5
313123	sucralfate 1 GM per 10 ML Oral Suspension	SY	c76c7bcb-d481-43ff-809b-da8e0e88f096	5

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
0121-0974-00	00121097400	10 TRAY in 1 TRAY (0121-0974-00) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10)	10 tray	2022-08-31	0000-00-00	No	No	Current
0121-0974-10	00121097410	10 mL in 1 CUP, UNIT-DOSE	10 ml					Historical
0121-0974-30	00121097430	3 TRAY in 1 CASE (0121-0974-30) > 10 CUP, UNIT-DOSE in 1 TRAY > 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10)	3 tray	2022-08-31	0000-00-00	No	No	Current
0121-0974-40	00121097440	4 TRAY in 1 CASE (0121-0974-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10)	4 tray	2022-08-31	0000-00-00	No	No	Current
0121-0974-50	00121097450	5 PACKAGE in 1 TRAY (0121-0974-50) / 10 CUP, UNIT-DOSE in 1 PACKAGE / 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10)	5 package	2022-08-31	0000-00-00	No	No	Current
0121-0974-94	00121097494	3 TRAY in 1 CASE (0121-0974-94) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (0121-0974-10)	3 tray	2022-08-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Sucralfate Oral Suspension	Cardinal Health 107, LLC	2026-03-30	HUMAN PRESCRIPTION DRUG LABEL	5
Sucralfate Oral Suspension	PAI Holdings, LLC dba PAI Pharma \| VistaPharm, LLC	2026-03-11	HUMAN PRESCRIPTION DRUG LABEL	6
Sucralfate Oral Suspension	Natco Pharma USA LLC	2024-07-03	HUMAN PRESCRIPTION DRUG LABEL	5